191 related articles for article (PubMed ID: 35054871)
1. Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients.
Santoni G; Amantini C; Nabissi M; Arcella A; Maggi F; Santoni M; Morelli MB
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054871
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients.
Santoni G; Maggi F; Amantini C; Arcella A; Marinelli O; Nabissi M; Santoni M; Morelli MB
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887088
[TBL] [Abstract][Full Text] [Related]
3. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.
Morelli MB; Nabissi M; Amantini C; Maggi F; Ricci-Vitiani L; Pallini R; Santoni G
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499683
[TBL] [Abstract][Full Text] [Related]
4. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q
Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-1.
Tomé M; Tchorz J; Gassmann M; Bettler B
Stem Cell Res; 2019 Mar; 35():101390. PubMed ID: 30763736
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
7. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
Chang HH; Cheng YC; Tsai WC; Chen Y
Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
[TBL] [Abstract][Full Text] [Related]
8. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
[TBL] [Abstract][Full Text] [Related]
9. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
[TBL] [Abstract][Full Text] [Related]
11. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Lucio-Eterovic AK; Piao Y; de Groot JF
Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
[TBL] [Abstract][Full Text] [Related]
13. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
[TBL] [Abstract][Full Text] [Related]
14. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
15. FGD5 sustains vascular endothelial growth factor A (VEGFA) signaling through inhibition of proteasome-mediated VEGF receptor 2 degradation.
Heldin J; O'Callaghan P; Hernández Vera R; Fuchs PF; Gerwins P; Kreuger J
Cell Signal; 2017 Dec; 40():125-132. PubMed ID: 28927665
[TBL] [Abstract][Full Text] [Related]
16. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
[No Abstract] [Full Text] [Related]
17. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
Sivasankaran B; Degen M; Ghaffari A; Hegi ME; Hamou MF; Ionescu MC; Zweifel C; Tolnay M; Wasner M; Mergenthaler S; Miserez AR; Kiss R; Lino MM; Merlo A; Chiquet-Ehrismann R; Boulay JL
Cancer Res; 2009 Jan; 69(2):458-65. PubMed ID: 19147558
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
[TBL] [Abstract][Full Text] [Related]
20. Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells.
Plesch E; Chen CC; Butz E; Scotto Rosato A; Krogsaeter EK; Yinan H; Bartel K; Keller M; Robaa D; Teupser D; Holdt LM; Vollmar AM; Sippl W; Puertollano R; Medina D; Biel M; Wahl-Schott C; Bracher F; Grimm C
Elife; 2018 Nov; 7():. PubMed ID: 30479274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]